CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Granulocyte Colony-Stimulating Factor +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04998279
NCT04998279N/ACompleted

Intrauterine Infusion of Granulocyte Colony Stimulating Factor and Reproductive Outcomes in Infertile Women with History of Recurrent Implantation Failure

Cairo University·observational·Posted Aug 10, 2021·Updated Oct 1, 2024

In Brief

An observational study evaluating Granulocyte Colony-Stimulating Factor and placebo for Recurrent Implantation Failure and 2 related conditions. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Intrauterine infusion of granulocyte colony stimulating factor and reproductive outcomes in infertile women with history of recurrent implantation failure

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 10, 2021
Enrollment StartSep 1, 2019
Primary CompletionAug 30, 2024
Study CompletionSep 25, 2024
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 4.9 years ago

Interventions

Granulocyte Colony-Stimulating Factordrug

Granulocyte-colony stimulating factors (G-CSF) is synthesized in the reproductive tract naturally, it is a hematopoietic lineage-specific cytokine which is known for its specific effects on the activation of intracellular signaling pathways that are associated with the cell proliferation, differentiation, and stimulation of hematopoietic cells of the neutrophilic granulocyte lineage; which act on macrophages of decidual cells and finally affect implantation

placeboother

mock test without injection of G-CSF